These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33482227)

  • 1. Negative emotions and cancer fatalism are independently associated with uptake of Faecal Immunochemical Test-based colorectal cancer screening: Results from a population-based study.
    Clarke N; Kearney PM; Gallagher P; McNamara D; O'Morain CA; Sharp L
    Prev Med; 2021 Apr; 145():106430. PubMed ID: 33482227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of gender on decisions to participate in faecal immunochemical test-based colorectal cancer screening: a qualitative study.
    Clarke N; Gallagher P; Kearney PM; McNamara D; Sharp L
    Psychooncology; 2016 Dec; 25(12):1456-1462. PubMed ID: 26864167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.
    Clarke N; McNamara D; Kearney PM; O'Morain CA; Shearer N; Sharp L
    Prev Med; 2016 Dec; 93():198-203. PubMed ID: 27765660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of defensive information processing in population-based colorectal cancer screening uptake.
    Clarke N; Hayes L; McQueen A; Gallagher P; Kearney PM; McNamara D; O'Morain CA; von Wagner C; Mooney T; Sharp L
    Cancer; 2023 Apr; 129(8):1253-1260. PubMed ID: 36740959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
    Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
    BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
    Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
    BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does theory of planned behaviour play a role in predicting uptake of colorectal cancer screening? A cross-sectional study in Hong Kong.
    Huang J; Wang J; Pang TW; Chan MK; Leung S; Chen X; Leung C; Zheng ZJ; Wong MC
    BMJ Open; 2020 Aug; 10(8):e037619. PubMed ID: 32764087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer.
    Hall NJ; Rubin GP; Dobson C; Weller D; Wardle J; Ritchie M; Rees CJ
    Health Expect; 2015 Oct; 18(5):1645-57. PubMed ID: 24268129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived barriers and benefits in the participation in faecal occult blood test colorectal cancer screening programme.
    Menéndez Rodríguez M; García-Morales N; Seoane Pillado T; Garau Ramírez J; Traver Salvador A; Hervás Jiménez Y; Pin Vieito N; Menéndez Rodríguez L; Cubiella J
    Gastroenterol Hepatol; 2023 Mar; 46(3):185-194. PubMed ID: 35605825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of marital status and partner concordance on participation in colorectal cancer screening.
    Gram MA; Therkildsen C; Clarke RB; Andersen KK; Mørch LS; Tybjerg AJ
    Eur J Public Health; 2021 Apr; 31(2):340-346. PubMed ID: 33417705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Flemish colorectal cancer screening programme reach equity in FIT uptake?
    Hoeck S; van de Veerdonk W; De Brabander I; Kellen E
    Eur J Public Health; 2019 Dec; 29(6):1108-1114. PubMed ID: 30887054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
    Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
    Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
    Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
    Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.